DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Posição atual:
>
> This Story


Início de uma sessão ou Registo to rate this News Story
Forward Printable StoryPrint Comment

 

 

Business Affairs Homepage

Dr. Martin T. Rothman Sofinnova Partners appoints venture partner

Three ways providers can improve patient satisfaction with online forms Tips for simplifying a historically tedious process

Strategies for rural health systems to remain competitive in today’s healthcare environment Three tips to help meet unique challenges

Cerner head suggests negative reports about DoD contract may be 'fake news' Suggests competitors may have played role in bad publicity

Study finds ultrasound and mammo have highest no-show rates Missed appointments at imaging facilities make up 3.25 percent of exams

FDA report opposes regulating third-party servicers Evidence for public health concern deemed 'not sufficient'

Change Healthcare, Adobe and Microsoft partner to address patient satisfaction Big names set their attention to a big problem

How SUD reprocessing delivers bigger value to health systems Lowering costs and reducing waste, the market is ripe for growth

Bronwen Taylor AdvaMed congratulates Stryker’s VP on 2018 PwC MedTech ethical leadership award

Device recalls skyrocket by 126 percent in first quarter of 2018 Software accounted for nearly a quarter of all recalls

Demonstration of Accurate's
anti-reflux microcatheters

Guerbet to buy Accurate Medical Therapeutics for over €19.5 million

por Lauren Dubinsky , Senior Reporter
Guerbet announced on Monday that it acquired Accurate Medical Therapeutics for an initial payment of EUR 19.5 million.

Additional payments will be made over the next few years depending on the achievement of regulatory and commercial milestones. The total amount will not surpass EUR 57 million.

Story Continues Below Advertisement

OR Tables, Treatment/GYN/Uro Chairs, Transport Stretchers, Hospital/ICU Bed

iMS combines the superior service of Oakworks Medical and advanced manufacturing technology of FAMED Medical Solutions. The goal of iMS, "Connecting Art and Medical Science" goes way beyond product with exceptional CareLink service. Contact us today!



Accurate has developed a portfolio of microcatheters for image-guided embolization procedures to treat tumors and vascular aneurysms. The products are currently being registered with the U.S. and European health authorities.

"This new range of microcatheters will allow us to help interventional radiology teams deliver a higher quality of care during image-guided embolization procedures," Yves L’Epine, CEO of the Guerbet, told HCB News.

The portfolio comprises two types of microcatheters. One was designed to improve intra-arterial navigation for interventional radiologists, even in the case of lesions that are difficult to access.

The other has the same navigation capabilities, as well as an anti-reflux technology. Side holes were placed in the terminal part of the catheter to create a fluid barrier that prevents the reflux of embolization microspheres.

That technology allows the interventional radiologist to deliver embolization microspheres to the targeted treatment area, while stopping them from refluxing upstream to arteries that irrigate healthy tissues.

Guerbet, which specializes in contrast agents and solutions for medical imaging, purchased Accurate to deepen its stake in the interventional radiology market and "round out its current portfolio," according to L'Epine.

"We want to leverage our expertise in interventional imaging built around the unique position of Lipiodol, standard of care for transarterial chemoembolization of liver cancers," he added.

The arterial embolization for tumors and aneurysms segment of the interventional radiology market is worth about EUR 600 million, according to Guerbet. The microcatheter portion of this segment accounts for EUR 120 million, and is growing at an annual rate of 5 to 10 percent.

The company is expected to start generating sales from this deal by the end of this year and be accretive from the fourth quarter of 2019.

Business Affairs Homepage


You Must Be Logged In To Post A Comment

Anuncie
Aumente a Sua Perceção da Marca
Leilões + Vendas Privadas
Comece
O mais melhor preço
Comprar Equipamento/Peças
Encontre
O preço o mais baixo
Notícia diária
Leia
A notícia a mais atrasada
Diretório
Browse tudo
DOTmed Usuários
Ética no DOTmed
Veja o nosso
Programa das éticas
O ouro parte o programa do vendedor
Receba PH
Pedidos
Programa do negociante do serviço do ouro
Receba RFP/PS
Pedidos
Fornecedores de Healthcare
Veja tudo
Ferramentas de HCP
Trabalhos/Treinamento
Achado/suficiência
Um trabalho
Parts Hunter +EasyPay
Comece as peças
Citações
Certificado recentemente
Vista recentemente
Usuários certificados
Recentemente Rated
Vista recentemente
Usuários certificados
Central Rental
Equipamento do aluguel
Para menos
Vender Equipamentos/Peças
Comece
A maioria de dinheiro
Preste serviços de manutenção ao Forum dos técnicos
Ajuda do achado
E conselho
Simples RFP
Comece o equipamento
Citações
Mostra de comércio virtual
Serviço do achado
Para o equipamento
O acesso e o uso deste local são sujeitos aos termos e às condições do nosso OBSERVAÇÃO LEGAL & OBSERVAÇÃO DA PRIVACIDADE
Propriedade de e proprietário DOTmeda .com, Inc. Copyright ©2001-2018 DOTmed.com, Inc.
TODOS OS DIREITOS RESERVADOS